https://orcid.org/0000-0002-8498-6107
Abstract
Objectives
To compare pregnancy outcomes after high-intensity focused ultrasound ablation (HIFU), myomectomy and uterine artery embolization (UAE) for fertility-sparing patients with uterine fibroids and to investigate the possible mechanism of improving pregnancy by HIFU.
Materials and methods
A meta-analysis of 54 studies containing 12,367 patients was conducted to compare the pregnancy outcomes of three fertility-sparing therapies. And a retrospective self-control study of 26 patients with uterine fibroids from May 2019 to December 2020 was performed to assess the blood flow impedance of bilateral uterine arteries before and after HIFU.
Results
In the analysis by treatment option, the pregnancy rate after myomectomy was 0.43 (95% CI 0.36–0.49), which was higher than 0.18 (95% CI 0.10–0.26) after HIFU, the latter was significantly higher than that after UAE (ratio 0.08, 95% CI 0.06–0.10). The miscarriage rate after HIFU was 0.08 (95% CI 0.04–0.12), which was similar to 0.15 (95% CI 0.09–0.21) after myomectomy and also similar to 0.16 after UAE (95% CI 0.01–0.30). In the subgroup analysis, women who received ultrasound guided HIFU (USgHIFU) were more likely to have ideal pregnancy outcomes than that after magnetic resonance imaging-guided HIFU. The pulsatility index and resistance index on the right side were significantly higher 3 months after HIFU than before (1.637 ± 0.435 vs. 1.845 ± 0.469; p = 0.033; 0.729 ± 0.141 vs. 0.784 ± 0.081, p = 0.039).
Conclusions
HIFU, especially USgHIFU, may be an alternative fertility-sparing modality for patients with uterine fibroids over 40 years old. HIFU may contribute to improving pregnancy rates by elevating uterine blood flow impedance.
Introduction
Uterine fibroids are prevalent noncancerous tumors in women of reproductive age [Citation1]. Fibroids impair fertility, and the treatments can also lead to subsequent fertility impairment. Current uterus-sparing treatments for fibroids include drug therapy, myomectomy, uterine artery embolization (UAE), high-intensity focused ultrasound ablation (HIFU) and so on. These techniques may have different degrees of influence on pregnancy [Citation2], but HIFU is noninvasive, repeatable, of less anesthesia involvement and more suitable for patients [Citation3]. Clinical follow-up results have found that HIFU could effectively improve the postoperative pregnancy rate of patients with uterine fibroids [Citation4]. However, some studies indicate that the reproductive outcome of HIFU is uncertain [Citation5–7].
There are also literatures that have revealed a correlation between sufficient uterine blood flow and fertility [Citation8,Citation9]. Hemodynamic parameters of uterine artery may be one of the effective indexes to evaluate endometrial receptivity [Citation10]. At present, the mechanism why HIFU can affect fertility is still unknown. Considering the relationship between uterine blood flow and fertility, the effect of HIFU ablation on uterine blood flow may be one of the reasons for improving pregnancy.
To study the role of HIFU for fertility improvement, we have carried out two parts of work. Firstly, a meta-analysis to compare the pregnancy outcomes of HIFU, myomectomy and UAE have been conducted; secondly, we have designed a retrospective study to demonstrate the improvement of the blood flow impedance before and after HIFU.
Materials and methods
Meta-analysis
Search strategy
PubMed, Cochrane Library and Embase electronic databases were thoroughly searched, and the following medical subject heading terms, keywords, and their combinations were used: high-intensity focused ultrasound ablation, HIFU, laparoscopy, laparoscopes, laparoscopic, laparotomy, laparotomy, laparotomies, abdominal, uterine artery embolization, UAE, leiomyoma, uterine fibroid, myoma, pregnancy, and fertility. The reviewed articles included primary research, such as randomized controlled trials (RCTs), cohort studies, case control studies and case series. The literature search was updated on August 2021.
Literature selection
Two reviewers (Li Yin and Li Fang) independently completed the initial title and abstract screening for all three databases. Full texts were retrieved when studies possibly met our inclusion criteria. Studies with the number of patients more than 30 and reported in the English language were considered eligible. Because not all patients could decide before surgery whether they want to get pregnant or not and that willingness could be changed in some time, a desire for future pregnancy was not considered as an inclusion criterium for each study. In case of disagreement, a third investigator was consulted (Fan Xu). Specific literature screening strategies are shown in .
Figure 1. Flow diagram of literature selection was shown, with the final number of studies as 54.
Data extraction and quality assessment
Two reviewers (Li Yin and Fang Li) independently extracted data from all eligible studies. Pregnancy outcomes were assessed by rates of pregnancy and miscarriage. The level of evidence of all articles were assessed independently by the same two authors according to the guidelines of the Newcastle–Ottawa Scale (NOS) for case-control studies. The higher the score of the study was, the higher its quality [Citation3]. In cases of discrepancy, the opinion of a third investigator was sought (Fan Xu).
Retrospective study
Patients
Between May 2019 and December 2020, twenty-six patients with a diagnosis of uterine fibroids who were hospitalized at Liuzhou Maternal and Child Health Care Hospital in Guangxi, China, were enrolled in this study. All of them had signed the informed consent. The HIFU ablation procedure has been described in the literature [Citation11]. Ethics approval for the study was granted by the research ethics committee of our hospital (NO. KS-KY-2019-005).
All patients who met the following criteria were included in the study: (1) confirmed diagnosis by enhanced magnetic resonance imaging (MRI); (2) diameters of fibroids ≥1 cm; (3) safe acoustic pathway. The exclusion criteria could also be referred to the literature [Citation11].
Bilateral Doppler flow velocity measurements were performed using a vaginal approach (Philips EPIQ 5, C10-3V, Netherlands). For the uterine artery spectral waveform analysis, manual tracing of the waveforms was performed to generate the Doppler parameters. The values of three consecutive waveforms were averaged, and the means were recorded. Moreover, the following parameters were recorded: the pulsatility index (PI), the resistance index (RI) and the ratio of the systolic peak value and the end-diastolic velocity of blood flow (S/D). Doppler measurements were performed 2–8 days before (median 3 days) and 3 months after HIFU by one of the two examiners. The effects on all subjects of this study were examined by T2-weighted MRI (T2WI) and T1-weighted MRI (T1WI) with gadolinium injection before, 1 day after and 3 months after HIFU.
Statistical analysis
The meta-analysis was performed with Stata (version 12), and were expressed as summary treatment effects (ratios) with corresponding 95% confidence intervals (CIs) for every intervention. A random-effects model was used for pooling the data. The I2 statistic was used to determine the heterogeneity. When I2 > 50% and p < 0.05, the between-study heterogeneity was considered to be significant. Publication bias was assessed using Egger’s test.
SPSS 26 (SPSS, Inc., Chicago, IL) was used for statistical analysis. Pregnancy rate equals (number of patients who became pregnant after treatment)/(number of patients who were treated); Miscarriage rate equals (number of patients who had a miscarriage)/(number of patients who became pregnant after treatment). Continuous variables were expressed as the means ± SEs and tested by using independent-sample t tests. Categorical data are expressed as percentages. p < 0.05 was considered statistically significant.
Results
Meta-analysis
Differences in pregnancy outcomes between HIFU and other treatments
Totally 5983 studies were screened and 54 studies were identified in the meta-analysis. In which 2687 patients were treated with HIFU, 6646 patients were treated with myomectomy, and 3034 patients were treated with UAE. Six studies were RCTs [Citation12–17], and 48 were non-randomized controlled studies (17 prospective [Citation18–34] and 31 retrospective [Citation2,Citation7,Citation35–63]). The main characteristics of the included studies are listed in .
Table 1. Characteristics and quality assessment of the included studies.
Pregnancy outcomes for patients with uterine fibroids from every study were extracted to our meta-analysis and distinguished into three groups: patients treated with HIFU, patients underwent myomectomy, and patients received UAE. The pregnancy rates of the different methods are listed in . In the overall analysis, the pregnancy rate after HIFU (ratio 0.18, 95% CI 0.10–0.26) was significantly higher than that after UAE (ratio 0.08, 95% CI 0.06–0.10) and significantly lower than that after myomectomy (Ratio 0.43, 95% CI 0.36–0.49). However, the pregnancy rates after USgHIFU (Ratio 0.35, 95% CI 0.16–0.53) was obviously higher than that after MRgHIFU (Ratio 0.06, 95% CI 0.04–0.08). And pregnancy rates after USgHIFU was similar to that after myomectomy [Ratio 0.35, 95% CI (0.16–0.53) vs. Ratio 0.43, 95% CI (0.36–0.49)] ().
Table 2. Pregnancy rate and miscarriage rate following HIFU and other surgical methods in the treatment of uterine fibroids.
Table 3. Pregnancy rate and miscarriage rate following USgHIFU and MRgHIFU in the treatment of uterine fibroids.
Nevertheless, the miscarriage rate after HIFU was similar to those after myomectomy and UAE [Ratio 0.08, 95% CI (0.04–0.12) vs Ratio 0.15, 95% CI (0.09–0.21) vs Ratio 0.16, 95% CI (0.01–0.30)] ().
Quality assessment and heterogeneity
In this review, we evaluated the quality of the studies based on the Newcastle-Ottawa scale for observational and nonrandomized studies. All studies had a score ranging from 3 to 8. Of them 6 studies were scored 3, 8 scored 4, 13 scored 5, 7 scored 6, 18 scored 7 and 2 scored 8 (). Studies were regarded as high quality researches only if they scored more than 4 [Citation64].
As there was heterogeneity among the pregnancy rate and miscarriage rate, the lower number of cases was considered as one of the reasons causing heterogeneity. Moreover, guiding methods of HIFU were explored that might partially explain high levels of heterogeneity. Subgroup analysis based on HIFU showed that the different guiding methods might be the sources of heterogeneity.
Publication bias
The publication bias of the studies was assessed with Egger’s test, and no significant publication bias was found (p > 0.05).
Retrospective study
Characteristics of patients and uterine hemodynamics data
All 26 patients underwent HIFU successfully without any severe complications. The general information of the patients is summarized in . The mean patient age was 35.38 ± 5.53 years (mean ± SD; range, 25–40 years), and mean BMI was 22.00 ± 3.28 kg/m2 (range, 20–25 kg/m2). Before the treatment, 46.2% of patients had menometrorrhagia, 57.7% of the patients had dysmenorrhea, 30.8% of the patients had polyuria and/or constipation, and 38.5% of the patients were diagnosed with anemia by routine blood tests.
The symptom severity scores (SSS) and Uterine Fibroid Symptom Quality of Life (UFS-QOL) questionnaire subscales, and the volume of fibroids before and 3 months after HIFU ablation showed significant differences. The hemodynamics data before and 3 months after HIFU ablation are summarized in . Although the PI and RI in the left side and the S/D were similar for both groups, the PI and RI in the right side were significantly higher 3 months after HIFU than before (1.637 ± 0.435 vs. 1.845 ± 0.469; p = 0.033; 0.729 ± 0.141 vs. 0.784 ± 0.081, p = 0.039). The self-control of PI, RI and S/D before and after HIFU are listed in .
Table 4. Characteristics of the patients with uterine fibroids treated with HIFU (n = 26).
Table 5. Self-control of PI, RI and S/D before and after HIFU.
Discussion
This was the first study to investigate the possible mechanism by a self-contrast approach and the first meta-analysis to compare the pregnancy outcomes of HIFU with those of other therapies. Unlike the pregnancy outcomes, in patients who received HIFU, the miscarriage rate was found similar to that after myomectomy or UAE. However, the pregnancy rate after USgHIFU was discovered similar to that after myomectomy. By comparing the changes of PI and RI in uterine arteries before and after HIFU treatment, we found that PI and RI in the right side of uterine artery were significantly increased after HIFU treatment.
Our study showed that the pregnancy rate after USgHIFU was similar to that after myomectomy, but significantly higher than that after UAE. Khaw supported the outcome that no statistically significant differences were found in pregnancy rate between HIFU ablation and myomectomy [Citation1]. The coagulative necrotic fibroid tissue was absorbed by surrounding tissues after HIFU ablation. With the reduction of fibroids, the structure and the environment of uterus gradually healed [Citation65]. It may be the reason that the pregnancy rate after USgHIFU was similar to that after myomectomy. Meanwhile, no report of uterine rupture during pregnancy or delivery after HIFU was found. However, the scar caused by myomectomy might lead to risk elevation of placental abnormality and uterine rupture [Citation66]. Furthermore, the reasons for low pregnancy rate after UAE was mainly the effect on the ovary blood supply and function of the endometrium.
Interestingly, when we scanned the characteristics of patients in all the literatures, we found that the ages of patients treated with HIFU for uterine fibroids ranged from 31.4 to 44.5 and those of patients underwent myomectomy ranged from 28 to 36.1. And the average ages of patients in seven studies were over 40 years old, but we could not do a pooled analysis as the ages of patients in some of the literature was recorded by median, and in others by mean. Since it would take time for patients who desired fertility to wait for the reconstruction of the myometrium after myomectomy, meanwhile, the ovarian function decreased rapidly over time, HIFU might be an alternative fertility-sparing modality for the patients with uterine fibroids over 40 years old.
In our study, the miscarriage rates after HIFU, myomectomy and UAE were similar. And only one relevant study reported that the miscarriage rate after HIFU was lower than that after myomectomy or UAE [Citation1]. Due to limited data, the mechanism of miscarriage after myomectomy remains unclear. However, high intensity focused ultrasound waves can be focused to coagulate the tumor cells on the targeted fibroids during ablation [Citation67], and the precise ablation can preserve the integrity of myometrium and endometrium [Citation68]. On the contrary, myomectomy impairs the integrity of the myometrium and endometrium. The influence of UAE on ovarian function, uterine perfusion, uterine cavity and endometrium may result in early pregnancy losses [Citation14]. In this sense, HIFU ablation may help to obtain ideal outcomes of pregnancy.
For the subgroup analysis, the pregnancy rate after USgHIFU was significantly higher than that after MRgHIFU, while the miscarriage rate was similar to that after MRgHIFU. Firstly, an MRgHIFU procedure could not be monitored in real time during treatment, so the operators might be relatively cautious about the ablation range. Secondly, in order to avoid the side effects of MRI contrast agents to patients, supplementary sonication was not allowed after the contrast-enhanced MRI [Citation69]. However, a higher none perfusion volume (NPV) ratio may be induced after USgHIFU since the ultrasound contrast imaging can be used to assess the need for supplementary sonication. Thus the NPV ratio of fibroids was smaller after MRgHIFU than that after USgHIFU [Citation49,Citation59]. A larger NPV ratio might indicate a better therapeutic effect after HIFU [Citation17].
The mechanism for improving pregnancy after HIFU treatment still lacks evidence. The blood supply to the uterus originates mainly from the uterine artery [Citation70]. The meta-analysis showed that a uterine artery PI of <3 measured on the day of fresh embryo transfer was associated with higher clinical pregnancy rates [Citation71]. Zhen Li reported that repeated implantation failure was positively correlated with uterine artery blood flow RI [Citation72]. But there was no literature report on whether S/D had an effect on pregnancy rate or not, but S/D remained an important indicator to evaluate fetal oxygen supply during pregnancy. The effect of HIFU on uterine artery blood flow is not clear. The authors found that PI and RI on the right side of the uterine artery were significantly increased after HIFU treatment. Ernest Hung Yu Ng and Pak Chung Ho also reported that PI and RI of the right uterine artery were much lower in patients with fibroids who failed to get pregnant, the same as the mean values of PI and RI in bilateral uterine arteries [Citation73]. Therefore, we hypothesized that the improvements in blood supply after HIFU affected the pregnancy rate.
We performed a broad search and discovered some explanations for the different pregnancy outcomes associated with different treatments. This study may provide much-needed information about treatments for uterine fibroids and pregnancy outcomes, which can help to advise the infertile women with fibroids. We are aware that the present study has some limitations. Firstly, we still need more RCTs to elucidate the results of this analysis in the future, although this meta-analysis can provide much needed information about treatments for uterine fibroids and may benefit in advising patients in terms of subsequent pregnancy. Secondly, the study on blood flow impedance remains only a hypothesis, which is hard to illustrate the effect of HIFU in pregnancy. Whether there are other possible mechanisms or not is still unclear. In view of the limitations of retrospective studies, we need to expand the sample size and design more prospective trials to further verify our hypothesis in the future. Thirdly, our meta-analysis might have some bias. However, we performed a subgroup analysis which hinted the pregnancy rate after USgHIFU was similar to that after myomectomy, but greater than that after MRgHIFU. Since MRgHIFU has been generally used in western countries, while USgHIFU has been widely used in China, different populations and guiding methods may have an impact on the heterogeneity. Therefore, more clinical trials on these two guidance methods are urgently needed to expand the sample size and to confirm our findings.
In conclusion, compared with myomectomy and UAE, HIFU, especially USgHIFU, maybe a fertility-sparing option for patients with uterine fibroids over 40 years old. HIFU may contribute to improving pregnancy rates through elevating the uterine blood flow impedance.
Geolocation information
1 Yixueyuan Road, Yuzhong District, Chongqing, P.R. China.
Disclosure statement
No potential conflicts of interest are reported by the author(s).
Data availability statement
The authors confirm that the data supporting the findings of this study are available within the article.
References
- Khaw SC, Anderson RA, Lui M. Response to comment on: systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids. Reprod Biomed Online. 2020;41(1):139.
- Zhang Y, Hua KQ. Patients’ age, myoma size, myoma location, and interval between myomectomy and pregnancy may influence the pregnancy rate and live birth rate after myomectomy. J Laparoendosc Adv Surg Tech A. 2014;24(2):95–99.
- Zhou YF. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol. 2011;2(1):8–27.
- Peregrino PFM, Messina MDL, Simoes RDS, et al. Review of magnetic resonance-guided focused ultrasound in the treatment of uterine fibroids. Clinics. 2017;72(10):637–641.
- Falcone T, Parker WH. Surgical management of leiomyomas for fertility or uterine preservation. Obstet Gynecol. 2013;121(4):856–868.
- Khaw SC, Anderson RA, Lui MW. Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids. Reprod Biomed Online. 2020;40(3):429–444.
- Zou M, Chen L, Wu C, et al. Pregnancy outcomes in patients with uterine fibroids treated with ultrasound-guided high-intensity focused ultrasound. BJOG. 2017;124(Suppl 3):30–35.
- Serafini P, Batzofin J, Nelson J, et al. Sonographic uterine predictors of pregnancy in women undergoing ovulation induction for assisted reproductive treatments. Fertil Steril. 1994;62(4):815–822.
- Coulam CB, Bustillo M, Soenksen DM, et al. Ultrasonographic predictors of implantation after assisted reproduction. Fertil Steril. 1994;62(5):1004–1010.
- Tong R, Zhou Y, He Q, et al. Analysis of the guidance value of 3D ultrasound in evaluating endometrial receptivity for frozen-thawed embryo transfer in patients with repeated implantation failure. Ann Transl Med. 2020;8(15):944.
- Fan HJ, Cun JP, Zhao W, et al. Factors affecting effects of ultrasound guided high intensity focused ultrasound for single uterine fibroids: a retrospective analysis. Int J Hyperthermia. 2018;35(1):534–540.
- Campo S, Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues. Hum Reprod. 1999;14(1):44–48.
- Chan CC, Lee CY. Feasibility and safety of absorbable knotless wound closure device in laparoscopic myomectomy. Biomed Res Int. 2016;2016:2849476.
- Mara M, Maskova J, Fucikova Z, et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol. 2008;31(1):73–85.
- Palomba S, Zupi E, Falbo A, et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes. Fertil Steril. 2007;88(4):933–941.
- Volkers NA, Hehenkamp WJ, Birnie E, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. Am J Obstet Gynecol. 2007;196(6):519.e1–11–519.11.
- Seracchioli R, Rossi S, Govoni F, et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod. 2000;15(12):2663–2668.
- Campo S, Campo V, Gambadauro P. Reproductive outcome before and after laparoscopic or abdominal myomectomy for subserous or intramural myomas. Eur J Obstet Gynecol Reprod Biol. 2003;110(2):215–219.
- Liu WM, Wang PH, Chou CS, et al. Efficacy of combined laparoscopic uterine artery occlusion and myomectomy via minilaparotomy in the treatment of recurrent uterine myomas. Fertil Steril. 2007;87(2):356–361.
- Wu G, Li R, He M, et al. A comparison of the pregnancy outcomes between ultrasound-guided high-intensity focused ultrasound ablation and laparoscopic myomectomy for uterine fibroids: a comparative study. Int J Hyperthermia. 2020;37(1):617–623.
- Mara M, Kubinova K, Maskova J, et al. Uterine artery embolization versus laparoscopic uterine artery occlusion: the outcomes of a prospective, nonrandomized clinical trial. Cardiovasc Intervent Radiol. 2012;35(5):1041–1052.
- Chen R, Keserci B, Bi H, et al. The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China. J Ther Ultrasound. 2016;4:27.
- Firouznia K, Ghanaati H, Sanaati M, et al. Pregnancy after uterine artery embolization for symptomatic fibroids: a series of 15 pregnancies. AJR Am J Roentgenol. 2009;192(6):1588–1592.
- Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–589.
- Holub Z, Mara M, Kuzel D, et al. Pregnancy outcomes after uterine artery occlusion: prospective multicentric study. Fertil Steril. 2008;90(5):1886–1891.
- Morita Y, Ito N, Hikida H, et al. Non-invasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fibroids – early experience. Eur J Obstet Gynecol Reprod Biol. 2008;139(2):199–203.
- Pinto Pabon I, Magret JP, Unzurrunzaga EA, et al. Pregnancy after uterine fibroid embolization: follow-up of 100 patients embolized using tris-acryl gelatin microspheres. Fertil Steril. 2008;90(6):2356–2360.
- Pron G, Mocarski E, Bennett J, et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol. 2005;105(1):67–76.
- Redecha M, Jr., Mizickova M, Javorka V, et al. Pregnancy after uterine artery embolization for the treatment of myomas: a case series. Arch Gynecol Obstet. 2013;287(1):71–76.
- Sizzi O, Rossetti A, Malzoni M, et al. Italian multicenter study on complications of laparoscopic myomectomy. J Minim Invasive Gynecol. 2007;14(4):453–462.
- Tian YC, Wu JH, Wang HM, et al. Improved fertility following enucleation of intramural myomas in infertile women. Chin Med J. 2017;130(14):1648–1653.
- Tinelli A, Hurst BS, Hudelist G, et al. Laparoscopic myomectomy focusing on the myoma pseudocapsule: technical and outcome reports. Hum Reprod. 2012;27(2):427–435.
- Torre A, Paillusson B, Fain V, et al. Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms. Hum Reprod. 2014;29(3):490–501.
- Walker WJ, Pelage JP. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG. 2002;109(11):1262–1272.
- Bernardi TS, Radosa MP, Weisheit A, et al. Laparoscopic myomectomy: a 6-year follow-up single-center cohort analysis of fertility and obstetric outcome measures. Arch Gynecol Obstet. 2014;290(1):87–91.
- Bonduki CE, Feldner PC, Jr., Silva J, et al. Pregnancy after uterine arterial embolization. Clinics. 2011;66(5):807–810.
- Carpenter TT, Walker WJ. Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. BJOG. 2005;112(3):321–325.
- Dessolle L, Soriano D, Poncelet C, et al. Determinants of pregnancy rate and obstetric outcome after laparoscopic myomectomy for infertility. Fertil Steril. 2001;76(2):370–374.
- Dutton S, Hirst A, McPherson K, et al. A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium-term safety and efficacy. BJOG. 2007;114(11):1340–1351.
- Floss K, Garcia-Rocha GJ, Kundu S, et al. Fertility and pregnancy outcome after myoma enucleation by minilaparotomy under microsurgical conditions in pronounced uterus myomatosus. Geburtshilfe Frauenheilkd. 2015;75(1):56–63.
- Froeling V, Meckelburg K, Schreiter NF, et al. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol. 2013;82(12):2265–2269.
- Kang SY, Jeung IC, Chung YJ, et al. Robot-assisted laparoscopic myomectomy for deep intramural myomas. Int J Med Robot. 2017;13:e1742.
- Keserci B, Duc NM. Volumetric magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids through abdominal scars: the impact of a scar patch on therapeutic efficacy and adverse effects. J Ther Ultrasound. 2017;5:22.
- Koo YJ, Lee JK, Lee YK, et al. Pregnancy outcomes and risk factors for uterine rupture after laparoscopic myomectomy: a single-center experience and literature review. J Minim Invasive Gynecol. 2015;22(6):1022–1028.
- Kumakiri J, Takeuchi H, Kitade M, et al. Pregnancy and delivery after laparoscopic myomectomy. J Minim Invasive Gynecol. 2005;12(3):241–246.
- Kundu S, Iwanuk C, Staboulidou I, et al. Morbidity, fertility and pregnancy outcomes after myoma enucleation by laparoscopy versus laparotomy. Arch Gynecol Obstet. 2018;297(4):969–976.
- Lee JS, Hong GY, Park BJ, et al. Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: a single center experience from the Republic of Korea. Ultrason Sonochem. 2015;27:682–687.
- Li JS, Wang Y, Chen JY, et al. Pregnancy outcomes in nulliparous women after ultrasound ablation of uterine fibroids: a single-central retrospective study. Sci Rep. 2017;7(1):3977.
- Liu X, Xue L, Wang Y, et al. Vaginal delivery outcomes of pregnancies following ultrasound-guided high-intensity focused ultrasound ablation treatment for uterine fibroids. Int J Hyperthermia. 2018;35(1):510–517.
- Lozinski T, Filipowska J, Gurynowicz G, et al. The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids - experiences from the main polish center and a review of current data. Int J Hyperthermia. 2019;36(1):582–590.
- McLucas B, Voorhees WD. 3rd. Results of UAE in women under 40 years of age. Minim Invasive Ther Allied Technol. 2014;23(3):179–183.
- Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol. 2015;25(5):1317–1328.
- Paul PG, Koshy AK, Thomas T. Pregnancy outcomes following laparoscopic myomectomy and single-layer myometrial closure. Hum Reprod. 2006;21(12):3278–3281.
- Pepin K, Dmello M, Sandberg E, et al. Reproductive outcomes following use of barbed suture during laparoscopic myomectomy. J Minim Invasive Gynecol. 2020;27(7):1566–1572.
- Pitter MC, Srouji SS, Gargiulo AR, et al. Fertility and symptom relief following robot-assisted laparoscopic myomectomy. Obstet Gynecol Int. 2015;2015:967568.
- Pitter MC, Gargiulo AR, Bonaventura LM, et al. Pregnancy outcomes following robot-assisted myomectomy. Hum Reprod. 2013;28(1):99–108.
- Qin J, Chen JY, Zhao WP, et al. Outcome of unintended pregnancy after ultrasound-guided high-intensity focused ultrasound ablation of uterine fibroids. Int J Gynaecol Obstet. 2012;117(3):273–277.
- Soriano D, Dessolle L, Poncelet C, et al. Pregnancy outcome after laparoscopic and laparoconverted myomectomy. Eur J Obstet Gynecol Reprod Biol. 2003;108(2):194–198.
- Thiburce AC, Frulio N, Hocquelet A, et al. Magnetic resonance-guided high-intensity focused ultrasound for uterine fibroids: mid-term outcomes of 36 patients treated with the sonalleve system. Int J Hyperthermia. 2015;31(7):764–770.
- Verpalen IM, de Boer JP, Linstra M, et al. The focused ultrasound myoma outcome study (FUMOS): a retrospective cohort study on long-term outcomes of MR-HIFU therapy. Eur Radiol. 2020;30(5):2473–2482.
- Xie L, Liu Y, Wang D, et al. Application of a 'baseball’ suture technique in uterine myomectomy following laparoscopic enucleation of uterine leiomyoma (fibroid). Med Sci Monit. 2018;24:3042–3049.
- Yoon SW, Cha SH, Ji YG, et al. Magnetic resonance imaging-guided focused ultrasound surgery for symptomatic uterine fibroids: estimation of treatment efficacy using thermal dose calculations. Eur J Obstet Gynecol Reprod Biol. 2013;169(2):304–308.
- Vimercati A, Del Vecchio V, Chincoli A, et al. Uterine rupture after laparoscopic myomectomy in two cases: real complication or malpractice? Case Rep Obstet Gynecol. 2017;2017:1404815.
- Ji Y, Hu K, Zhang Y, et al. High-intensity focused ultrasound (HIFU) treatment for uterine fibroids: a meta-analysis. Arch Gynecol Obstet. 2017;296(6):1181–1188.
- Hanstede MM, Tempany CM, Stewart EA. Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report. Fertil Steril. 2007;88(2):497.e5–7–497.e7.
- Vilos GA, Allaire C, Laberge PY, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–178.
- Rabinovici J, David M, Fukunishi H, et al. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010;93(1):199–209.
- Tempest N, Hapangama D. Should we be putting our scalpels down? Is HIFU the answer to fertility-sparing fibroid treatment? BJOG. 2018;125(3):366.
- Wang Y, Wang ZB, Xu YH. Efficacy, efficiency, and safety of magnetic resonance-guided high-intensity focused ultrasound for ablation of uterine fibroids: comparison with ultrasound-guided method. Korean J Radiol. 2018;19(4):724–732.
- Cicinelli E, Einer-Jensen N, Galantino P, et al. The vascular cast of the human uterus: from anatomy to physiology. Ann N Y Acad Sci. 2004;1034:19–26.
- Craciunas L, Gallos I, Chu J, et al. Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(2):202–223.
- Li Z, Wang X, Guan Y, et al. Uterine artery blood flow and microvessel density by vaginal color doppler ultrasonography in embryo implantation failure. Exp Ther Med. 2017;14(5):4797–4800.
- Ng EH, Ho PC. Doppler ultrasound examination of uterine arteries on the day of oocyte retrieval in patients with uterine fibroids undergoing IVF. Hum Reprod. 2002;17(3):765–770.